Asset Management
Compare Stocks
4 / 10Stock Comparison
AB vs IVZ vs BEN vs TROW
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
AB vs IVZ vs BEN vs TROW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $4.40B | $11.92B | $15.86B | $22.54B |
| Revenue (TTM) | $333M | $6.38B | $8.77B | $7.31B |
| Net Income (TTM) | $300M | $-243M | $812M | $2.09B |
| Gross Margin | 100.0% | 43.2% | 80.3% | 62.7% |
| Operating Margin | 100.0% | -10.9% | 6.9% | 29.9% |
| Forward P/E | 11.5x | 10.4x | 11.2x | 11.2x |
| Total Debt | $0.00 | $10.12B | $13.30B | $860M |
| Cash & Equiv. | $0.00 | $1.98B | $3.57B | $3.38B |
AB vs IVZ vs BEN vs TROW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AllianceBernstein H… (AB) | 100 | 159.5 | +59.5% |
| Invesco Ltd. (IVZ) | 100 | 336.6 | +236.6% |
| Franklin Resources,… (BEN) | 100 | 161.8 | +61.8% |
| T. Rowe Price Group… (TROW) | 100 | 85.7 | -14.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AB vs IVZ vs BEN vs TROW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AB is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 2 yrs, beta 0.60, yield 8.8%
- 199.2% 10Y total return vs TROW's 93.6%
- Beta 0.60 vs IVZ's 1.67
- 8.8% yield, 2-year raise streak, vs BEN's 4.3%
IVZ carries the broadest edge in this set and is the clearest fit for growth and value.
- 5.1% NII/revenue growth vs AB's -28.0%
- Lower P/E (10.4x vs 11.2x)
- +93.1% vs AB's +3.2%
BEN is the clearest fit if your priority is growth exposure.
- Rev growth 3.5%, EPS growth 7.1%
TROW is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.18, Low D/E 7.1%, current ratio 73.08x
- Beta 1.18, yield 4.9%, current ratio 73.08x
- Efficiency ratio 0.3% vs BEN's 0.7% (lower = leaner)
- Efficiency ratio 0.3% vs BEN's 0.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.1% NII/revenue growth vs AB's -28.0% | |
| Value | Lower P/E (10.4x vs 11.2x) | |
| Quality / Margins | Efficiency ratio 0.3% vs BEN's 0.7% (lower = leaner) | |
| Stability / Safety | Beta 0.60 vs IVZ's 1.67 | |
| Dividends | 8.8% yield, 2-year raise streak, vs BEN's 4.3% | |
| Momentum (1Y) | +93.1% vs AB's +3.2% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs BEN's 0.7% |
AB vs IVZ vs BEN vs TROW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AB vs IVZ vs BEN vs TROW — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AB leads in 2 of 6 categories
IVZ leads 2 • BEN leads 0 • TROW leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AB leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BEN is the larger business by revenue, generating $8.8B annually — 26.4x AB's $333M. AB is the more profitable business, keeping 90.1% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $333M | $6.4B | $8.8B | $7.3B |
| EBITDAEarnings before interest/tax | $243M | $1.2B | $1.2B | $2.7B |
| Net IncomeAfter-tax profit | $300M | -$243M | $812M | $2.1B |
| Free Cash FlowCash after capex | $352M | $1.9B | $938M | $2.3B |
| Gross MarginGross profit ÷ Revenue | +100.0% | +43.2% | +80.3% | +62.7% |
| Operating MarginEBIT ÷ Revenue | +100.0% | -10.9% | +6.9% | +29.9% |
| Net MarginNet income ÷ Revenue | +90.1% | -4.4% | +6.0% | +28.5% |
| FCF MarginFCF ÷ Revenue | +105.9% | +22.6% | +10.4% | +20.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -2.2% | +34.2% | +100.0% | +3.7% |
Valuation Metrics
IVZ leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 11.2x trailing earnings, TROW trades at a 67% valuation discount to BEN's 33.5x P/E. On an enterprise value basis, TROW's 7.6x EV/EBITDA is more attractive than BEN's 22.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $4.4B | $11.9B | $15.9B | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $4.4B | $20.1B | $25.6B | $20.0B |
| Trailing P/EPrice ÷ TTM EPS | 13.41x | -16.77x | 33.54x | 11.20x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.52x | 10.44x | 11.21x | 11.22x |
| PEG RatioP/E ÷ EPS growth rate | 18.67x | — | — | — |
| EV / EBITDAEnterprise value multiple | 18.11x | 16.34x | 22.53x | 7.64x |
| Price / SalesMarket cap ÷ Revenue | 13.23x | 1.87x | 1.81x | 3.08x |
| Price / BookPrice ÷ Book value/share | 3.25x | 0.94x | 1.11x | 1.92x |
| Price / FCFMarket cap ÷ FCF | 12.49x | 8.27x | 17.40x | 15.24x |
Profitability & Efficiency
AB leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
AB delivers a 18.8% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-2 for IVZ. TROW carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to BEN's 0.94x. On the Piotroski fundamental quality scale (0–9), IVZ scores 6/9 vs TROW's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +18.8% | -1.7% | +5.6% | +17.6% |
| ROA (TTM)Return on assets | +18.7% | -0.9% | +2.5% | +14.4% |
| ROICReturn on invested capital | +15.3% | -2.3% | +1.6% | +13.3% |
| ROCEReturn on capital employed | +20.3% | -2.6% | +2.0% | +15.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 4 |
| Debt / EquityFinancial leverage | — | 0.78x | 0.94x | 0.07x |
| Net DebtTotal debt minus cash | $0 | $8.1B | $9.7B | -$2.5B |
| Cash & Equiv.Liquid assets | $0 | $2.0B | $3.6B | $3.4B |
| Total DebtShort + long-term debt | $0 | $10.1B | $13.3B | $860M |
| Interest CoverageEBIT ÷ Interest expense | — | -6.19x | 15.19x | — |
Total Returns (Dividends Reinvested)
IVZ leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AB five years ago would be worth $12,550 today (with dividends reinvested), compared to $6,915 for TROW. Over the past 12 months, IVZ leads with a +93.1% total return vs AB's +3.2%. The 3-year compound annual growth rate (CAGR) favors IVZ at 21.6% vs TROW's 3.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +5.5% | +0.4% | +29.6% | +0.2% |
| 1-Year ReturnPast 12 months | +3.2% | +93.1% | +55.5% | +18.9% |
| 3-Year ReturnCumulative with dividends | +40.9% | +79.8% | +35.3% | +11.5% |
| 5-Year ReturnCumulative with dividends | +25.5% | +8.2% | +7.4% | -30.9% |
| 10-Year ReturnCumulative with dividends | +199.2% | +22.1% | +23.5% | +93.6% |
| CAGR (3Y)Annualised 3-year return | +12.1% | +21.6% | +10.6% | +3.7% |
Risk & Volatility
Evenly matched — AB and BEN each lead in 1 of 2 comparable metrics.
Risk & Volatility
AB is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BEN currently trades 97.1% from its 52-week high vs TROW's 87.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.60x | 1.67x | 1.31x | 1.18x |
| 52-Week HighHighest price in past year | $44.11 | $29.61 | $31.44 | $118.22 |
| 52-Week LowLowest price in past year | $35.59 | $14.10 | $20.08 | $85.51 |
| % of 52W HighCurrent price vs 52-week peak | +90.3% | +90.6% | +97.1% | +87.6% |
| RSI (14)Momentum oscillator 0–100 | 60.3 | 69.4 | 78.4 | 78.2 |
| Avg Volume (50D)Average daily shares traded | 312K | 5.1M | 5.1M | 2.3M |
Analyst Outlook
Evenly matched — AB and BEN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AB as "Buy", IVZ as "Hold", BEN as "Hold", TROW as "Hold". Consensus price targets imply 10.8% upside for IVZ (target: $30) vs -5.8% for BEN (target: $29). For income investors, AB offers the higher dividend yield at 8.76% vs IVZ's 3.10%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $40.75 | $29.72 | $28.75 | $101.20 |
| # AnalystsCovering analysts | 13 | 28 | 27 | 38 |
| Dividend YieldAnnual dividend ÷ price | +8.8% | +3.1% | +4.3% | +4.9% |
| Dividend StreakConsecutive years of raises | 2 | 4 | 6 | 3 |
| Dividend / ShareAnnual DPS | $3.49 | $0.83 | $1.33 | $5.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +15.6% | +1.5% | +2.8% |
AB leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IVZ leads in 2 (Valuation Metrics, Total Returns). 2 tied.
AB vs IVZ vs BEN vs TROW: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AB or IVZ or BEN or TROW a better buy right now?
For growth investors, Invesco Ltd.
(IVZ) is the stronger pick with 5. 1% revenue growth year-over-year, versus -28. 0% for AllianceBernstein Holding L. P. (AB). T. Rowe Price Group, Inc. (TROW) offers the better valuation at 11. 2x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate AllianceBernstein Holding L. P. (AB) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AB or IVZ or BEN or TROW?
On trailing P/E, T.
Rowe Price Group, Inc. (TROW) is the cheapest at 11. 2x versus Franklin Resources, Inc. at 33. 5x. On forward P/E, Invesco Ltd. is actually cheaper at 10. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AB or IVZ or BEN or TROW?
Over the past 5 years, AllianceBernstein Holding L.
P. (AB) delivered a total return of +25. 5%, compared to -30. 9% for T. Rowe Price Group, Inc. (TROW). Over 10 years, the gap is even starker: AB returned +199. 2% versus IVZ's +22. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AB or IVZ or BEN or TROW?
By beta (market sensitivity over 5 years), AllianceBernstein Holding L.
P. (AB) is the lower-risk stock at 0. 60β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 179% more volatile than AB relative to the S&P 500. On balance sheet safety, T. Rowe Price Group, Inc. (TROW) carries a lower debt/equity ratio of 7% versus 94% for Franklin Resources, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AB or IVZ or BEN or TROW?
By revenue growth (latest reported year), Invesco Ltd.
(IVZ) is pulling ahead at 5. 1% versus -28. 0% for AllianceBernstein Holding L. P. (AB). On earnings-per-share growth, the picture is similar: Franklin Resources, Inc. grew EPS 7. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AB or IVZ or BEN or TROW?
AllianceBernstein Holding L.
P. (AB) is the more profitable company, earning 90. 1% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 90. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AB leads at 100. 0% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — AB leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AB or IVZ or BEN or TROW more undervalued right now?
On forward earnings alone, Invesco Ltd.
(IVZ) trades at 10. 4x forward P/E versus 11. 5x for AllianceBernstein Holding L. P. — 1. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IVZ: 10. 8% to $29. 72.
08Which pays a better dividend — AB or IVZ or BEN or TROW?
All stocks in this comparison pay dividends.
AllianceBernstein Holding L. P. (AB) offers the highest yield at 8. 8%, versus 3. 1% for Invesco Ltd. (IVZ).
09Is AB or IVZ or BEN or TROW better for a retirement portfolio?
For long-horizon retirement investors, AllianceBernstein Holding L.
P. (AB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60), 8. 8% yield, +199. 2% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AB: +199. 2%, IVZ: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AB and IVZ and BEN and TROW?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AB is a small-cap deep-value stock; IVZ is a mid-cap income-oriented stock; BEN is a mid-cap income-oriented stock; TROW is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.